Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma

Update Il y a 4 ans
Reference: NCT02923531

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine if the combination of X4P-001 plus nivolumab is safe and tolerable. Secondly, the study will investigate if adding X4P-001 to nivolumab treatment has an effect on the body and the cancer tumor, in patients receiving nivolumab but not exhibiting a radiological response.


Inclusion criteria

  • Clear Cell Renal Cell Carcinoma

Links